semaglutide eye disease Wegovy Vision Loss Lawsuit [2026 Update] Ophthalmological Examination Before Semaglutide Therapy

[Published correction appears in N Engl J Med

Typically, people see noticeable weight loss results from oral semaglutide within the first three months

All PlexusDx medications come from licensed 503A compounding pharmacies that meet strict federal manufacturing standards for sterility, potency, and purity

This protocol outlines evidence-based guidance for safe clinical application

This step-by-step approach, called dose titration, helps make treatment easier to tolerate while still allowing the medication to work effectively

Wegovy is approved for use in non-diabetic adults with a BMI of 30 or greater, or those with a BMI of 27 or greater with weight-related medical problems such as high blood pressure or high cholesterol